EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transition
about
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancerLulu2 regulates the circumferential actomyosin tensile system in epithelial cells through p114RhoGEFFERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progressionP53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAsEffects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural developmentLeft-right patterning in the mouse requires Epb4.1l5-dependent morphogenesis of the node and midlineThe epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets.Lulu regulates Shroom-induced apical constriction during neural tube closure.Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.Human axonal survival of motor neuron (a-SMN) protein stimulates axon growth, cell motility, C-C motif ligand 2 (CCL2), and insulin-like growth factor-1 (IGF1) production.Increased expression of FERM domain-containing 4A protein is closely associated with the development of rectal cancerLysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer.Tetraspanin18 is a FoxD3-responsive antagonist of cranial neural crest epithelial-to-mesenchymal transition that maintains cadherin-6B protein.p120catenin alteration in cancer and its role in tumour invasion.ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance.Adhesive and signaling functions of cadherins and catenins in vertebrate development.High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue.Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAsYMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinomaAssociation of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression.The CRB1 Complex: Following the Trail of Crumbs to a Feasible Gene Therapy Strategy.Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).Molecular mechanisms of cell shape changes that contribute to vertebrate neural tube closure.Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT).Gbx2 directly restricts Otx2 expression to forebrain and midbrain, competing with class III POU factors.Epithelial Mesenchymal Transition: a double-edged sword.Alternative splicing of genes during neuronal differentiation of NT2 pluripotential human embryonal carcinoma cells.Epb41l5 competes with Delta as a substrate for Mib1 to coordinate specification and differentiation of neurons.The circumferential actomyosin belt in epithelial cells is regulated by the Lulu2-p114RhoGEF system.Neurogenin3 initiates stepwise delamination of differentiating endocrine cells during pancreas development.Mib1 contributes to persistent directional cell migration by regulating the Ctnnd1-Rac1 pathway.Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells.Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.Whole-transcriptome splicing profiling of E7.5 mouse primary germ layers reveals frequent alternative promoter usage during mouse early embryogenesis.Computational identification and validation of alternative splicing in ZSF1 rat RNA-seq data, a preclinical model for type 2 diabetic nephropathy.
P2860
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
P248
Q21132487-DFA0E08E-C20A-43A4-9019-76A1A62752AFQ24293613-6528B2C6-0EDA-4C10-8061-C7F54BB65D35Q24294440-54C922DE-48D0-4D5A-8702-59B2A074B2B6Q27308938-07A03C6F-3FB7-49B4-A65B-9AD765F8D36DQ27322700-C8385292-7F45-40BF-A267-22B6E8CFADCCQ28488341-D753D9AD-DC09-431F-A631-2A692B95D783Q28510954-E8B3697E-E9F1-4761-99FE-D9A07E44F55DQ33661198-2C0FF54B-C0F6-464C-BFC0-D17DAA382B6AQ33790864-EB431255-21D6-44F0-9BB8-0A5D731107E8Q34537141-E5D4B78F-A1CA-4C46-8F3D-563139FEF213Q35055387-048CDAE9-28AD-4D3B-9507-017AA5204FE5Q35973315-E6E59F4B-1E35-49D1-A632-74EE0D0453CCQ36122082-D2F4D0C8-CC34-46D7-A5CC-5D9CD4715942Q36524489-99F635B9-4E79-41B8-A12B-14FF36A07877Q36564705-6BA30B4C-1364-4770-B1A8-16512662BA29Q36815735-BDAAE18A-88A6-479A-BE0F-A7FD64606ADCQ37204601-9A47EDA3-F4BE-483D-A932-5D9B927E60DBQ37306553-46FD8E7F-281B-474B-9515-A4310E340058Q37412685-9E1D0BF6-54E2-43AC-B18D-34056AFDB2E9Q37426556-58C12D04-685F-4B72-AFB7-9A9639D693DDQ37504561-BA9CBCA4-A848-480C-BF05-CC4A65D7C0F0Q37687422-9BACFF25-E273-433B-A2CC-78A90464B815Q37688277-9C18862F-A6B1-427E-87ED-0F5211DFF8FFQ37707088-B69C397A-E328-4C03-84A6-659E9FFF56FEQ37737543-11D48361-BCC5-4E5F-A768-1C61477BADDBQ37986326-C2E7015E-7836-48E6-8C8A-520048355C4FQ38004609-4B0324FD-ADEE-4D2E-A628-7D1199706AADQ38006770-1F8D8799-A4A0-4C4F-9D01-86BA9E47DC58Q38325585-418FA3EA-294E-4C3F-A5D2-EBF11DB7179FQ38453116-1E58C114-7EC2-4DA3-B6BB-50A9F896EF3BQ39664891-AC398F33-8DA2-4BC9-BA67-575DDFBA11BDQ41285172-B71DB922-5FEA-40EE-B34C-5725711C6995Q41948066-1CD53541-467C-477E-ADF3-4ABAC27D8DCCQ42483413-959C01FA-EE59-4091-810C-1CF805573EC8Q47403051-BF1592D7-A8AA-4A8A-92A4-6AF22DCA2A49Q48295154-781D9CEA-09C8-469A-B027-B160F50A6A72Q49413628-BF45F8B3-F476-4FC8-801F-50A5F6EC00D0Q52723519-F7A4C3FE-27B6-4819-950F-93376DAB9AD6Q55023730-6EF21E55-AA67-4603-8E06-26E5ABF87954
P2860
EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transition
description
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im September 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/09/22)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/09/22)
@nl
наукова стаття, опублікована у вересні 2008
@uk
مقالة علمية (نشرت في 22-9-2008)
@ar
name
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@ast
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@en
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@nl
type
label
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@ast
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@en
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@nl
prefLabel
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@ast
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@en
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@nl
P2093
P2860
P921
P3181
P356
P1476
EPB41L5 functions to post-tran ...... thelial-mesenchymal transition
@en
P2093
Hisataka Sabe
Mariko Hirano
Shigenobu Yonemura
Shigeru Hashimoto
Shinichi Aizawa
P2860
P304
P3181
P356
10.1083/JCB.200712086
P407
P577
2008-09-22T00:00:00Z